These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9584269)

  • 1. Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency).
    Barone R; Carchon H; Jansen E; Pavone L; Fiumara A; Bosshard NU; Gitzelmann R; Jaeken J
    J Inherit Metab Dis; 1998 Apr; 21(2):167-72. PubMed ID: 9584269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).
    Carchon H; Van Schaftingen E; Matthijs G; Jaeken J
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):155-65. PubMed ID: 10571009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins.
    Jaeken J; Artigas J; Barone R; Fiumara A; de Koning TJ; Poll-The BT; de Rijk-van Andel JF; Hoffmann GF; Assmann B; Mayatepek E; Pineda M; Vilaseca MA; Saudubray JM; Schlüter B; Wevers R; Van Schaftingen E
    J Inherit Metab Dis; 1997 Jul; 20(3):447-9. PubMed ID: 9266378
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.
    Van Schaftingen E; Jaeken J
    FEBS Lett; 1995 Dec; 377(3):318-20. PubMed ID: 8549746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance.
    Jaeken J; Pirard M; Adamowicz M; Pronicka E; van Schaftingen E
    Pediatr Res; 1996 Nov; 40(5):764-6. PubMed ID: 8910943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).
    Grünewald S; Schollen E; Van Schaftingen E; Jaeken J; Matthijs G
    Am J Hum Genet; 2001 Feb; 68(2):347-54. PubMed ID: 11156536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological presentation of a congenital disorder of glycosylation CDG-Ia: implications for diagnosis and genetic counseling.
    Drouin-Garraud V; Belgrand M; Grünewald S; Seta N; Dacher JN; Hénocq A; Matthijs G; Cormier-Daire V; Frébourg T; Saugier-Veber P
    Am J Med Genet; 2001 Jun; 101(1):46-9. PubMed ID: 11343337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate-deficient glycoprotein syndromes: the Italian experience.
    Di Rocco M; Barone R; Adami A; Burlina A; Carrozzi M; Dionisi-Vici C; Gatti R; Iannetti P; Parini R; Raucci U; Roccella M; Spada M; Fiumara A
    J Inherit Metab Dis; 2000 Jun; 23(4):391-5. PubMed ID: 10896302
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I.
    Mayatepek E; Schröder M; Kohlmüller D; Bieger WP; Nützenadel W
    Acta Paediatr; 1997 Oct; 86(10):1138-40. PubMed ID: 9350901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycosylation of a brain glycoprotein (beta-trace protein) in CDG syndromes due to phosphomannomutase deficiency and N-acetylglucosaminyl-transferase II deficiency.
    Pohl S; Hoffmann A; Rüdiger A; Nimtz M; Jaeken J; Conradt HS
    Glycobiology; 1997 Dec; 7(8):1077-84. PubMed ID: 9455908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological findings in a case of carbohydrate-deficient glycoprotein (CDG) syndrome type I with phosphomannomutase deficiency.
    Veneselli E; Biancheri R; Di Rocco M; Tortorelli S
    Eur J Paediatr Neurol; 1998; 2(5):239-44. PubMed ID: 10726826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].
    Sätilä H; Kuusela AL; Pietilä K; Niinikoski H; Keskinen P
    Duodecim; 2016; 132(3):253-9. PubMed ID: 26951030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I.
    Beccari T; Mancuso F; Costanzi E; Tassi C; Barone R; Fiumara A; Orlacchio A; Aisa MC; Orlacchio A
    Clin Chim Acta; 2000 Dec; 302(1-2):125-32. PubMed ID: 11074069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannose supplementation in carbohydrate-deficient glycoprotein syndrome type I and phosphomannomutase deficiency.
    Mayatepek E; Kohlmüller D
    Eur J Pediatr; 1998 Jul; 157(7):605-6. PubMed ID: 9686827
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased expression of beta-hexosaminidase alpha chain in cultured skin fibroblasts from patients with carbohydrate-deficient glycoprotein syndrome type I.
    Ichisaka S; Ohno K; Yuasa I; Nanba E; Sakuraba H; Suzuki Y
    Brain Dev; 1998 Aug; 20(5):302-6. PubMed ID: 9760999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of the carbohydrate-deficient glycoprotein syndrome type 1A (CDG1A) by a combination of enzymology and genetic linkage analysis after amniocentesis or chorionic villus sampling.
    Charlwood J; Clayton P; Keir G; Mian N; Young E; Winchester B
    Prenat Diagn; 1998 Jul; 18(7):693-9. PubMed ID: 9706650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients.
    Freeze HH
    Biochim Biophys Acta; 2009 Sep; 1792(9):835-40. PubMed ID: 19339218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate-deficient glycoprotein syndrome due to phosphomannomutase deficiency: the first reported cases from Latin America.
    de Michelena MI; Franchi LM; Summers PG; De La Fuente C; Campos PJ; Jaeken J
    Am J Med Genet; 1999 Jun; 84(5):481-3. PubMed ID: 10360403
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).
    Grünewald S
    Biochim Biophys Acta; 2009 Sep; 1792(9):827-34. PubMed ID: 19272306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity.
    Freeze HH; Aebi M
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):167-78. PubMed ID: 10571010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.